Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

0.2515

+0.0073 (2.99%)

At close: May 8, 2025, 4:00 PM

0.2500

-0.0015 (-0.60%)

After-hours: May 8, 2025, 4:06 PM EDT

Cellectar Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-44.58	-42.77	-31.79	-24.12	-15.09	Upgrade
Depreciation & Amortization	0.29	0.19	0.15	0.15	0.14	Upgrade
Loss (Gain) From Sale of Assets	0.15	-	0	0	-	Upgrade
Stock-Based Compensation	4.27	2.41	1.45	1.12	0.47	Upgrade
Other Operating Activities	-5.99	4.32	3.28	0.08	-0.12	Upgrade
Change in Accounts Payable	-1.59	3.7	1.62	0.41	0.78	Upgrade
Change in Other Net Operating Assets	-0.13	-0.22	0.06	-0.21	-0.11	Upgrade
Operating Cash Flow	-47.58	-32.38	-25.22	-22.57	-13.93	Upgrade
Capital Expenditures	-0.1	-0.86	-0.23	-0.14	-0.06	Upgrade
Investing Cash Flow	-0.1	-0.86	-0.23	-0.14	-0.06	Upgrade
Long-Term Debt Issued	-	-	-	-	0.18	Upgrade
Total Debt Issued	-	-	-	-	0.18	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	0.18	Upgrade
Issuance of Common Stock	61.41	22.94	9.61	1.25	60.36	Upgrade
Financing Cash Flow	61.41	22.94	9.61	1.25	60.55	Upgrade
Net Cash Flow	13.72	-10.3	-15.84	-21.46	46.55	Upgrade
Free Cash Flow	-47.69	-33.24	-25.45	-22.71	-14	Upgrade
Free Cash Flow Per Share	-1.28	-2.72	-3.61	-4.09	-7.06	Upgrade
Cash Interest Paid	-	-	-	-	0	Upgrade
Levered Free Cash Flow	-43.97	-8.99	-8.83	-13.63	-8.23	Upgrade
Unlevered Free Cash Flow	-43.97	-8.99	-8.83	-13.63	-8.23	Upgrade
Change in Net Working Capital	16.07	-13.62	-7.8	-0.32	-0.78	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q